Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma

Clinical trial NCT03012880 · COMPLETED

Trial details

NCT number: NCT03012880
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plasma Cell Myeloma

Start date: 2017-04-20
Primary completion: 2022-12-15
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.